Glaucoma: all 1,844 studies

Page 15 of 19. Open to participants first (233), then studies with results posted, then the rest; newest registration first within each.

• Use of Intravitreal Triamcinolone and Retrobulbar Chlorpromazine as Alternatives to the Management of Painful Blind EyeCompletedNCT01404364Not applicable
• Evaluation of Safety and Efficacy of Glaucoma Shunt (Aurolab Artificial Drainage Implant) in Refractory GlaucomaStatus unknownNCT01401088Phase 4
• Imaging of Trabeculectomy Blebs Using the Spectral Domain Optical Coherence TomographyCompletedNCT01391676
• Validation of Retinal Oximetry in Glaucoma Patients: a Structural and Functional CorrelationCompletedNCT01391247
• Comparison of Sensimed Triggerfish With Goldmann Applanation Tonometry and Perkins TonometryCompletedNCT01391078Not applicable
• EXTERNAL SLT Treatment in Patients With Uncontrolled OPEN ANGLE GLAUCOMACompletedNCT01384149Phase 1
• Direct Application of Selective Laser Trabeculoplasty in Open Angle GlaucomaCompletedNCT01383525Not applicable
• A Study Comparing The Efficacy, Safety And Tolerability Of Latanoprost 75, 100 And 125 ug/ml To Xalatan In The Treatment Of Primary Open-Angle Glaucoma And Ocular HypertensionCompletedNCT01379144Phase 2
• Assessment of Advanced Glaucomatous Visual Field Loss and Its Impact on Visual Exploration, Activities of Daily Living (ADL) and Quality of Life (QoL)CompletedNCT01372319
• Clinical Validation Study of RTVue FeaturesCompletedNCT01370850
• Study to Evaluate the Effects of Ranibizumab (Lucentis) for Patients With Rubeosis and Neovascular GlaucomaCompletedNCT01370135Not applicable
• Selective Lasertrabeculoplasty and Ocular Hemodynamics in GlaucomaCompletedNCT01363362Not applicable
• Effects of Latanoprost, Bimatoprost and Travoprost in Patients With Latanoprost-resistant GlaucomaStatus unknownNCT01361841Not applicable
• The Effect of Body Posture on Intraocular Pressure in Progressive GlaucomaStatus unknownNCT01351779
• Prospective Study Phase: Retinal Oxygen Saturation, Blood Flow, Vascular Function and High Resolution Morphometric Imaging in the Living Human EyeStatus unknownNCT01348672
• a 3.0T Magnetic Resonance Imaging StudyStatus unknownNCT01346904
• Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Brimonidine TherapyStatus unknownNCT01345448Phase 2
• Glaucoma Treatment by Circular Cyclocoagulation Using High Intensity Focused Ultrasound With the EYEOP Medical DeviceCompletedNCT01338467Not applicable
• 24-hour Efficacy of AR-12286CompletedNCT01330979Phase 2
• SENSIMED TriggerfishCompletedNCT01319604Not applicable
• Ocular Rigidity and Outflow Facility in Glaucomatous and Normal EyesStatus unknownNCT01315340Not applicable
• Advanced Imaging for Glaucoma StudyCompletedNCT01314326
• Evaluation of Efficacy and Safety of Susanna Implant in Patients With Refractory Glaucoma.Status unknownNCT01314170Phase 3
• Safety and Intraocular Pressure (IOP) Lowering Effect of AL-59412CTerminatedNCT01312454Phase 2
• Trabeculectomy With Subconjunctival Bevacizumab InjectionCompletedNCT01310764Not applicable
• Tafluprost-Timolol Fixed Dose Combination Non-Inferiority Study Against Concomitant AdministrationsCompletedNCT01306461Phase 3
• Effect of Yellow-Tinted Intraocular Lens on Standard Automated Perimetry (SAP) and Short-wavelength Automated Perimetry (SWAP) in Patients With and Without GlaucomaCompletedNCT01305616Not applicable
• Intraocular Pressure, Blood Pressure, Ocular Perfusion and Blood Flow Fluctuations in Glaucoma PatientsCompletedNCT01304264
• AR-12286 in Combination With LatanoprostCompletedNCT01302249Phase 2
• Patch Graft Material Safety and Effectiveness in Covering Glaucoma Drainage Device TubeTerminatedNCT01301378Not applicable
• Divided Dose of TRAVATAN®CompletedNCT01298687Phase 2
• Comparison of Phacotrabeculectomy and Trabeculectomy in the Treatment of Primary Angle-closure Glaucoma (PACG)CompletedNCT01298635Not applicable
• Comparison of Two Method Antimetabolites Application on Corneal Function in Trabeculectomy SurgeryStatus unknownNCT01297803Phase 2
• Choroidal Thickness in Glaucoma Patients and Healthy ControlsStatus unknownNCT01293474
• Tafluprost-Timolol Preservative-free Fixed Dose Combination (FDC) Superiority Study Against MonotherapiesCompletedNCT01292460Phase 3
• Evaluation of Filtering Blebs Using the "Wuerzburg Bleb Classification Score" Compared to Other Clinical Findings, e.g. the Intraocular Pressure (IOP)CompletedNCT01287442
• Hydroxypropylmethylcellulose 0.3% and Sodium Hyaluronate 0.18% for Ocular Surface Disease in GlaucomaStatus unknownNCT01284439Not applicable
• Safety and Efficacy of Triple Combination Therapy With Dorzolamide Hydrochloride / Brimonidine Tartrate / Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular HypertensionWithdrawnNCT01284166Phase 3
• SOLX Gold Shunt for Refractory GlaucomaCompletedNCT01282346Not applicable
• Adherence With Fixed Versus Unfixed Glaucoma TherapyCompletedNCT01281020
• Safety and Efficacy Trial to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01279083Phase 1/2
• Reproducibility of Nerve Fiber Layer Thickness Measurements in Patients With Glaucoma and Healthy Controls Using Spectral-Domain and Time-Domain OCTTerminatedNCT01273285Phase 4
• Macular Ganglion Cell Analysis (GCA) of the Cirrus HD-OCT in GlaucomaCompletedNCT01272102
• Comparison of Anterior Chamber Paracentesis and Conventional Mannitol Infusion in Patients With Primary Acute Angle-closure GlaucomaCompletedNCT01266343
• Results of Adjunctive Intraoperative Bevacizumab Injection on Trabeculectomy OutcomeCompletedNCT01263834Phase 2/3
• Use of an Ocular Telemetry Sensor in Tafluprost Treated PatientsTerminatedNCT01263535Phase 4
• Clinical Effectiveness of Low Vision Rehabilitation in Glaucoma PatientsCompletedNCT01262209Not applicable
• Safety and Efficacy Study of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® to Treat Glaucoma and Ocular Surface DiseaseCompletedNCT01254370Phase 2
• Saccadic Eye Movements Are Impaired In GlaucomaStatus unknownNCT01254058
• Retinal Nerve Fibres Layers Thickness Study in Glaucomatous PatientsCompletedNCT01254006Not applicable
• Continuous Intraocular Pressure (IOP) Monitoring in Pigmentary Dispersion Syndrome and Pigmentary Glaucoma PatientsTerminatedNCT01253109
• A Prospective Evaluation of Open-Angle Glaucoma Subjects on Two Topical Hypotensive Medications Treated With One Suprachoroidal StentCompletedNCT01252914Phase 4
• Prospective Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medication Treated With Two iStentsCompletedNCT01252888Phase 4
• Prospective Evaluation of Open-Angle Glaucoma Subjects on One Topical Hypotensive Medication Treated With Two iStentsCompletedNCT01252862Phase 4
• Purpose of This Study is to Evaluate the Safety and Efficacy of One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma SubjectsCompletedNCT01252849Not applicable
• The Effect of Selective Laser Trabeculoplasty (SLT) on Ocular RigidityCompletedNCT01247831Not applicable
• Safety and Efficacy of Changing to DuoTrav From Prior TherapyCompletedNCT01230736Phase 4
• A Study Evaluating the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle GlaucomaCompletedNCT01229982Phase 2
• Use of Bevacizumab to Modulate the Outcomes of Trabeculectomy SurgeryWithdrawnNCT01229202Phase 4
• Trabeculectomy Versus CanaloplastyCompletedNCT01228799Not applicable
• Reproducibility of Retinal Nerve Fiber Layer Thickness Measurements Using the Eye Tracker and Retest Function of Spectralis® SD-OCT in Glaucomatous Eyes and Healthy ControlsTerminatedNCT01228721Phase 4
• SYL040012. Tolerance and Effect on Intraocular Pressure in Subjects With Intraocular Pressure (IOP) >= 21 mm HgCompletedNCT01227291Phase 1/2
• Polarization Sensitive Retinal Tomography for Glaucoma DiagnosisCompletedNCT01222065
• Surgical Treatment of Refractory Open Angle GlaucomaCompletedNCT01212861Not applicable
• Retinal Vascular Reactivity in Subjects With Newly Diagnosed Glaucoma Before and After Selective Laser TrabeculoplastyStatus unknownNCT01209975
• Phaco vs. Phaco-ELT vs. Phaco-Trabectome 12mCompletedNCT01194310
• Autonomic Nervous System Activity and Normal Tension GlaucomaCompletedNCT01192061
• Retinal Nerve Fiber Layer Thickness Measurements in Patients With Sleep Apnea SyndromeCompletedNCT01188291
• Safety Study of Latanoprost Slow Release InsertTerminatedNCT01180062Phase 1
• Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Trabeculectomy: A Study in GermanyStatus unknownNCT01174420Not applicable
• Assessment of Retinal Nerve Fibre Layer by Optical Coherence Tomography in Uveitis Patients With PapilloedemaCompletedNCT01170481
• A Study of Ganfort Versus Duotrav in Patients With Primary Open Angle Glaucoma or Ocular HypertensionCompletedNCT01168414Phase 3
• Latanoprost Versus Tafluprost: 24-hour Intraocular Pressure (IOP)CompletedNCT01162603Phase 4
• Prospective Retinal and Optic Nerve Vitrectomy Evaluation (PROVE) StudyCompletedNCT01162356
• Baerveldt Plate Area Comparison (BPAC)TerminatedNCT01159314Not applicable
• The Study of Ocular Hemodynamics With Glaucoma ProgressionCompletedNCT01145911
• Mechanism of Aphakic and Pseudophakic Glaucoma in Pediatric PatientsCompletedNCT01136473
• Genetic Testing in Primary Congenital Glaucoma PatientsStatus unknownNCT01136460
• Ahmed Valve Glaucoma Implant With Adjunctive Subconjunctival Bevacizumab in Refractory GlaucomaStatus unknownNCT01128699Phase 3
• Randomized Prospective Study of Selective Laser Trabeculoplasty (SLT) Versus Argon Trabeculoplasty (ALT) in Patients With Pseudoexfoliation Glaucoma and Ocular HypertensionCompletedNCT01126203Phase 3
• Efficiency of XAL-EASE Device in Glaucoma and/or Ocular Hypertension (OHT) Patients, Treated With Xalatan or XalacomStatus unknownNCT01125306Phase 4
• A Dose-Escalation Study Designed to Evaluate the Tolerability, Safety, Pharmacokinetics (PK), and Efficacy of Chronic Topical Ocular Application of INO-8875 in Adults With Ocular Hypertension or Primary Open-Angle GlaucomaCompletedNCT01123785Phase 1/2
• The Effect of Bevacizumab on the TrabeculectomyStatus unknownNCT01122966Phase 2/3
• The Influence of Anterior Chamber Fluid Mediators on the Success Rate of TrabeculectomyCompletedNCT01115218
• Comparison of the Efficacy of AZARGA® Versus COSOPT® in Patients With Open-Angled Glaucoma or Ocular HypertensionCompletedNCT01111890Phase 4
• CyPass Clinical Experience StudyCompletedNCT01097174
• Bimatoprost Versus Travoprost at Cairo UniversityCompletedNCT01092273
• Response to SLT vs. ALT in Patients Under 60 Years of AgeCompletedNCT01087684Not applicable
• Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost to Preservative Free Tafluprost Eye DropsCompletedNCT01087671Phase 3
• Comparison of Critical Flicker Fusion Versus Automated Visual Fields in the Detection of Early GlaucomaCompletedNCT01076114
• Comparison of Visual Fields: Humphrey Field Analyzer (HFA) SITA Strategy, SCOPE (GATE Strategy) and Humphrey MATRIX PerimeterStatus unknownNCT01068938
• The Performances of Spectral Domain Optical Coherence Tomography (OCT) for Distinguishing Glaucomatous EyesCompletedNCT01067482
• Study of AR-12286 Versus Latanoprost in Patients With Elevated Intraocular PressureCompletedNCT01060579Phase 2
• Evaluation of OT-135P (IOPtiMateTM) : Beam Manipulating System for CO2 Laser Assisted Non-Penetrating Glaucoma SurgeryStatus unknownNCT01059162Not applicable
• Impact Post-operative Treatment on Intraocular Pressure Post-SLT on Patients With Primary Open-angle GlaucomaCompletedNCT01058278Not applicable
• ELAZOP Switching Study in KoreaCompletedNCT01055366Phase 4
• GTS400 Stent Implantation in Conjunction With Cataract Surgery in Subjects With Open-angle GlaucomaCompletedNCT01052558Phase 3
• Avastin as an Adjunct to Diode Laser in the Treatment of Neovascular GlaucomaCompletedNCT01051583Phase 2
• Relationship Between Eye Pressure and Ganglion Cell Function in Eyes Receiving Latanoprost Versus PlaceboCompletedNCT01042665
• A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAGCompletedNCT01037036Phase 2

← Glaucoma overview